Organizations Filed Purposes:
THE SPECIFIC PURPOSE OF THE CORPORATION SHALL INCLUDE WITHOUT LIMITATION: TO EVOLVE AND PROVIDE RESEARCH, TRAINING, AND EDUCATION IN THE DEVELOPMENT OF KETAMINES USE FOR PSYCHIATRIC AND PSYCHOTHERAPEUTIC SCIENCE AND CLINICAL PRACTICE.
KETAMINE IS THE ONLY LEGALLY AVAILABLE MEDICINE WITH PSYCHEDELIC PROPERTIES, THE FIRST IN THE TOOLBOX. THIS ENABLES THE DEVELOPMENT OF THERAPEUTIC METHODOLOGIES AND PRACTICES THAT WILL SERVE AS OTHER MEDICINES BECOME AVAILABLE. IT MAKES FOR STREAMLINED AND CREATIVE RESEARCH WITH APPROPRIATE SAFEGUARDS AND IRB APPROVALS. THE SPECTRUM OF PROGRAMS AND PROJECTS THAT ARE PART OF THE DEVELOPING KETAMINE RESEARCH FOUNDATION EXEMPLIFIES THIS AND OUR DEDICATION TO COLLABORATION, AN INTERNATIONAL ORGANIZATIONAL PRESENCE, AND THE FULFILLMENT OF KETAMINES PROMISE AS AN EXTRAORDINARY AGENT OF CHANGE AND GROWTH.
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
| Name | Title | Hours Per Week | Total Salary |
|---|
| Julane Andries | SECRETARY | 0 | $0 |
| Garry Bravo | CHIEF FINANCIAL OFFICER | 0 | $0 |
| Philip E Wolfson | OFFICER | 0 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202042899349300544_public.xml